to produce natural medicines with technology to
provide personalized psychedelic medicine.
A world where humans lead healthy and deeply fulfilling lives
because safe psychedelic therapies are accessible and wellness
practices are integrated into mainstream culture.
Today, psychedelic therapies are only available as a last resort. We’re changing that. Human-centric, wellness-focused mental health care puts psychedelic therapies as the first line of treatment.
Most companies that offer psychedelic therapies don’t offer the preparation and integration needed to achieve meaningful and lasting results. We’re making an integrative approach to health and wellness the gold standard.
Minorities are greatly underrepresented in psychedelic studies and safe access to these therapies is limited to a wealthy few. To create the world we want to live in, we’re helping make safe and effective psychedelic therapies accessible to all humans.
|Wake Network, Inc. Receives Certificate of Drug Registration for Microdose Formulation in Jamaica||September 23, 2021||Download|
|Wake Network Inc. Subsidiary MagicBio Research Inc. Receives a Health Canada Exemption for Research and Development on Psilocybin and Psilocin Biosynthesis||August 24, 2021||Download|
|Wake Network, Inc. and the Lieber Institute for Brain Development Announce Research Collaboration||July 21, 2021||Download|
|Wake Network Appoints David Hackett as Chief Financial Officer||June 30, 2021||Download|
|Wake Network Retains CRO Sante Cannabis to Conduct Clinical Trials in Psilocybin Therapies||June 16, 2021||Download|